About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in San Antonio | 55 Studies

Clinical Trials HypertensionSan Antonio

Hypertension Clinical Trials in San Antonio

Find 55 clinical trials for hypertension near San Antonio, Texas. Connect with research centers in your area.

All Hypertension trials nationwide All trials in San Antonio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 55 trials

TerminatedA Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional TreatmentSelexipag is available in many countries for the treatment of pulmonary arterial hypertension (PAH).NCT03689244·La Jolla, California and 161 others

Hypertension Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingOpen-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionThis study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypertensionNCT05968430·Birmingham, Alabama and 176 others

Active not recruitingRADIANCE Continued Access ProtocolRADIANCE CAP is a non-randomized study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System, and to allow for the on-going…NCT05017935·Chula Vista, California and 39 others

UnknownProspective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular PressureProspective, double-masked, randomized, multi-center, active-controlled, parallel-group, 3-month study assessing the safety and ocular hypotensive efficacy of TearClear…NCT05165290·Garden Grove, California and 19 others

CompletedA Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 StudyThis is a Phase III, randomized, double-masked, active-controlled, parallel-group, multi-center study.NCT03691649·Phoenix, Arizona and 46 others

CompletedEfficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are FC II or III.NCT05934526·Birmingham, Alabama and 165 others

CompletedFREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)This study was an international, multicenter, randomized (2:1 active:placebo), double-blind, placebo-controlled study in subjects with PAH who were NOT currently receiving…NCT00325403·Birmingham, Alabama and 76 others

CompletedLevels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary StudyThe goals of this trial are to determine the prognostic significance of an elevated level of inflammatory blood markers in people who have experienced small subcortical strokes…NCT00579306·Mobile, Alabama and 44 others

RecruitingClevidipine for the Antihypertensive Treatment of Acute Intracerebral HemorrhageThe aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine…NCT06402968·Irvine, California and 19 others

CompletedInvestigation of the Safety and Pharmacology of Dry Powder Inhalation of TreprostinilThe primary objective of this study is to evaluate the long-term safety and tolerability of LIQ861, a dry powder formulation of treprostinil, in patients with Pulmonary Arterial…NCT03399604·Phoenix, Arizona and 37 others

Enrolling by invitationAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0There is a growing focus on short- and long-term kidney health in neonates, including those with acute kidney injury (AKI).NCT06823115·Birmingham, Alabama and 86 others

RecruitingEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseThis study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease.NCT07064473·Anniston, Alabama and 1141 others

CompletedExamining the Individual Response to a Restricted Sodium Diet in Hypertensive PatientsExcessive dietary sodium intake is an independent risk factor for hypertension and cardiovascular disease.NCT04764253·San Antonio, Texas

CompletedPulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier DetectionStudy GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial…NCT05776225·Phoenix, Arizona and 41 others

CompletedA Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)A number of blood pressure lowering drugs in the class known as angiotensin receptor blockers (ARB) have been shown to slow the decline in kidney function of patients with type 2…NCT00168857·Montgomery, Alabama and 108 others

CompletedEfficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant HypertensionThis is a Phase 3 trial to evaluate the BP-lowering effect of lorundrostat (an aldosterone synthase inhibitor) in subjects with uncontrolled and resistant hypertension taking…NCT06153693·Alexander City, Alabama and 183 others

CompletedRamipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential HypertensionThe purpose of this study is to determine if there is greater blood pressure reduction using ramipril or hydrochlorothiazide alone or ramipril and hydrochlorothiazide together.NCT00355589·Birmingham, Alabama and 59 others

CompletedEfficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous PatientsThe main study purpose is to demonstrate the non-inferiority of T4032 compared to Lumigan® 0.01% in terms of efficacy.NCT05397600·Chandler, Arizona and 63 others

CompletedA Registry for Patients Taking UptraviThis is a US multi-center, prospective, real world, observational drug registry enrolling patients actively treated with Uptravi.NCT03278002·Mobile, Alabama and 84 others

CompletedEmricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal HypertensionThis is a multicenter, randomized, double-blind, placebo-controlled trial involving subjects with NASH cirrhosis and severe portal hypertension (defined as HVPG ≥12 mmHg as…NCT02960204·Pasadena, California and 36 others

Page 1 of 3Next

Other Conditions in San Antonio

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia